SequelSEC

DELCATH SYSTEMS, INC. DCTH

Surgical & Medical Instruments & Apparatus · CIK 0000872912 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$95.42M
Fiscal year ended 2026-06-30
Operating income
-$1.81M
Fiscal year ended 2026-06-30
Free cash flow
$17.51M
Fiscal year ended 2026-06-30

DELCATH SYSTEMS, INC. (DCTH) reported revenue of $95.42M and net income of $532.00K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from DELCATH SYSTEMS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

DELCATH SYSTEMS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$95.42M
Cost of revenue$12.36M
Gross profit$83.06M
Operating income-$1.81M
Net income$532.00K
Research & development$37.56M
Weighted-average diluted sharesUnavailable
Pretax income$1.29M
Income tax expense$760.00K
Diluted EPSUnavailable
Selling, general & administrative$47.32M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

DELCATH SYSTEMS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$47.52M
Total assets$137.02M
Current assets$130.54M
Total liabilities$15.87M
Current liabilities$13.28M
Total equity incl. NCI$121.14M
Temporary (mezzanine) equityUnavailable
Inventory$11.71M
Accounts receivable$15.94M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$4.01M

Cash flow

DELCATH SYSTEMS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$19.59M
Capital expenditures$2.08M
Investing cash flow-$2.10M
Financing cash flow-$4.26M
Net change in cash$13.10M
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

DELCATH SYSTEMS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$17.51M
Gross margin87.1%
Operating margin-1.9%
FCF margin18.3%
SBC / revenueUnavailable
Current ratio9.83x
Revenue YoY growth35.8%
Net margin0.6%
R&D / revenue39.4%
CapEx / revenue2.2%
Long-term debt / equityUnavailable
Effective tax rate58.8%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DCTH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.